Schonfeld Strategic Advisors’s Bausch Health BHC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$100K	Sell	18,536 -128,547	-87%	-$769K	﹤0.01%	1886
2025 Q4	$1.02M	Buy	147,083 +132,409	+902%	+$871K	﹤0.01%	1119
2025 Q3	$94.6K	Buy	+14,674	New	+$100K	﹤0.01%	2025
2023 Q1	–	Sell	-118,920	Closed	-$747K	–	2114
2022 Q4	$747K	Buy	118,920 +118,820	+118,820%	+$830K	0.01%	1311
2022 Q3	$1K	Sell	100 -14,000	-99%	-$97.2K	﹤0.01%	2840
2022 Q2	$118K	Buy	+14,100	New	+$197K	﹤0.01%	2086
2017 Q1	–	Sell	-120,474	Closed	-$1.75M	–	597
2016 Q4	$1.75M	Buy	120,474 +41,631	+53%	+$764K	0.23%	132
2016 Q3	$1.94M	Sell	78,843 -64,357	-45%	-$1.67M	0.33%	78
2016 Q2	$2.88M	Buy	143,200 +77,492	+118%	+$2.19M	0.65%	30
2016 Q1	$1.73M	Buy	+65,708	New	+$4.86M	0.7%	28

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Schonfeld Strategic Advisors's BHC Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its Bausch Health (BHC) stake by 87% in Q1 2026, selling an estimated $769K and leaving 18,536 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #1886.

Schonfeld Strategic Advisors first reported a position in BHC in Q1 2016 and has held it in 10 quarters since. The position peaked at $2.88M in Q2 2016. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

Schonfeld Strategic Advisors held 18,536 shares of Bausch Health worth $100K as of Q1 2026.
Schonfeld Strategic Advisors sold 128,547 Bausch Health shares in Q1 2026, an estimated $769K.
Bausch Health made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1886 holding.
Schonfeld Strategic Advisors first reported a position in Bausch Health in Q1 2016 and has held it in 10 quarters since.
Schonfeld Strategic Advisors's Bausch Health position peaked at $2.88M in Q2 2016.
227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.